Association Between Driving Transpulmonary Pressure and Extravascular Lung Water in Patients with ARDS
1 other identifier
observational
100
1 country
1
Brief Summary
Intubated patients with the acute respiratory distress syndrome (ARDS) are usually treated with protective ventilation limiting plateau pressure below 30 centimeter of water (cmH2O) and, if possible, a driving pressure under 15 cmH2O. However, these airway pressures might not reflect the actual pressure applied to the lung. Transpulmonary pressure is the difference between airway pressure and pleural pressure, the latter is estimated by the esophageal pressure, and so it better reflects the ventilatory induced lung injury (VILI). One of the consequences of the VILI is a increase of pulmonary edema and it could be estimated by the extravascular lung water, obtained by trans-pulmonary thermodilution. So it could exist a link between the driving trans-pulmonary pressure and the extravascular lung water.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2022
CompletedFirst Submitted
Initial submission to the registry
July 19, 2022
CompletedFirst Posted
Study publicly available on registry
July 26, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2025
CompletedFebruary 11, 2025
February 1, 2025
3.6 years
July 19, 2022
February 9, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Association between the transpulmonary driving pressure and the extravascular lung water (EVLW)
On the first day of patient's respiratory and hemodynamics monitoring, we will collect transpulmonary driving pressure and extra-vascular lung water values. We will calculate the correlation coefficient linking these two variables to assess if their association.
From inclusion up to hospital discharge (maximum day 60)
Secondary Outcomes (7)
Association between the transpulmonary driving pressure and the pulmonary vascular permeability index (PVPI)
From inclusion up to hospital discharge (maximum day 60)
Correlation between the transpulmonary driving pressure at admission and the ICU-mortality
From inclusion up to hospital discharge (maximum day 60)
Correlation between the extravascular lung water at admission and the ICU-mortality
From inclusion up to hospital discharge (maximum day 60)
Influence of position on plateau pressure
From inclusion up to hospital discharge (maximum day 60)
Influence of position on plateau pressure on esophageal pressure
From inclusion up to hospital discharge (maximum day 60)
- +2 more secondary outcomes
Eligibility Criteria
Patients intubated in the medical ICU of Bicêtre hospital (Academic hospital), Le Kremlin Bicêtre, France
You may qualify if:
- Acute respiratory distress syndrome (ARDS)
- Monitoring with a transpulmonary thermodilution device
- Esophageal pressure monitoring
You may not qualify if:
- Legal protection measures
- Pregnancy
- Contra-indications of esophageal catheter : esophageal varicose, severe coagulopathy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Bicetre Hospitallead
Study Sites (1)
Medical Intensive Care Unit, Bicêtre Hospital
Le Kremlin-Bicêtre, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tài Pham, MD, PhD
Hôpital Bicêtre
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 19, 2022
First Posted
July 26, 2022
Study Start
February 1, 2022
Primary Completion
September 1, 2025
Study Completion
September 1, 2025
Last Updated
February 11, 2025
Record last verified: 2025-02